Stem Cell Research and News: United Kingdom
<-- Back To RegionsAutologous Stem Cell Transplantation For Relapsed Hodgkin’s Lymphoma
Royal Marsden Hospital,Fred Hutchinson Cancer Research Center,autologous stem cell transplantation,ASCT,Hodgkin’s lymphoma,HL,mediastinal,malignant,myeloid leukemia,myelodysplastic syndrome
Posted in Today's Stem Cell Research on July 28, 2008 02:34 PM
Research Studies Confirm Promise of Novel Cord Blood Stem Cell from BioE
BioE(R), Inc., a biomedical company providing non-embryonic, human stem cells, announced today that studies conducted by researchers at the University of Newcastle upon Tyne in the United Kingdom and the University of Minnesota in Minneapolis confirm the promise of the...
Posted in Today's Stem Cell Research on January 13, 2006 02:49 PM
GE Healthcare and ThermoGenesis Announce Worldwide Distribution Agreement and R&D Collaboration
CHALFONT ST. GILES, England and RANCHO CORDOVA, Calif., Oct. 14 - GE Healthcare, a unit of General Electric Company (NYSE: GE), and ThermoGenesis (Nasdaq: KOOL) announced today a global distribution agreement and R&D partnership. The companies will jointly present the...
Posted in Today's Stem Cell Research on November 3, 2005 02:26 PM
Chemokine Therapeutics Expands Protection of Core Anti-Cancer Technology with Issuance of New U.S. Patent
Vancouver, BC (October 5, 2005) – Chemokine Therapeutics Corp. (the Company) (OTCBB: CHKT; TSX: CTI), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, cardiovascular, and infectious diseases, today announced that it has been granted U.S. Patent No....
Posted in Today's Stem Cell Research on October 21, 2005 01:37 PM
New Life Scientific, Inc. and UTEK Corporation Announce Strategic Alliance Agreement
FREEHOLD, N.J. and PLANT CITY, Fla. - Sept. 22, 2005 - New Life Scientific, Inc. (OTCBB:NWLF), a company engaged in developing stem cell banks and stem cell treatment facilities, and UTEK Corporation (AMEX:UTK) (LSE-AIM:UTKA), an innovative technology transfer company, announced...
Posted in Today's Stem Cell Research on October 4, 2005 05:58 PM
Serologicals Corporation to Receive Start Magazine’s 2005
President & CEO David A. Dodd, Previously Named One of Start’s CEO Visionaries, Featured Speaker at Manufacturing Conference ATLANTA, GA – August 9, 2005 – Serologicals Corporation (NASDAQ: SERO) announced today that it has been awarded an Editor’s Choice Technology...
Posted in Today's Stem Cell Research on August 9, 2005 05:54 PM
New Method Proves It Possible To Grow Bone For Grafts Within A Patient's Body
These of the kinds of press releases that make my sore knee less sore. An international team of biomedical engineers has demonstrated for the first time that it is possible to grow healthy new bone reliably in one part of...
Posted in Today's Stem Cell Research on July 27, 2005 04:11 PM
Some Alternatives to Embryonic Stem Cell Resources Covered
Cryo-Cell International Inc., as many of us know, is a umbilical cord blood banking firm that processes and stores stem cells. Currently, its affiliate, Saneron CCEL Therapeutics Inc., does research on the uses of cord blood stem cells to find...
Posted in Today's Stem Cell Research on July 25, 2005 03:31 PM
Canada's Bioms Medical Commences U.K. Patient Enrollment in Multiple Sclerosis Trial
Edmonton, Alberta, July 21, 2005 - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the first patients in the United Kingdom have been enrolled in its pivotal Phase II/III clinical...
Posted in Today's Stem Cell Research on July 22, 2005 05:15 PM
CalbaTech LifeStem Subsidiary Files for Key Patent for Its Stem Cell Delivery Device
IRVINE, Calif. -- CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, announced today that its wholly owned subsidiary,...
Posted in Today's Stem Cell Research on June 16, 2005 12:19 PM
Human Cloning Foundation hails Newcastle University
The Human Cloning Foundation (HCF) hailed recent news that a University of Newcastle team in the United Kingdom had successfully cloned a human embryo in Britain for the first time. “The significance of this achievement is that the cloned human...
Posted in Today's Stem Cell Research on May 30, 2005 03:30 PM
BioMS Medical announces first quarter 2005 results
EDMONTON, May 13 /CNW/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced results for the first quarter ended March 31, 2005. "During the quarter, we initiated patient dosing for our...
Posted in Today's Stem Cell Research on May 13, 2005 03:15 PM
Stem Cell Sciences (STEM) Corp. Sheet
Stem Cell Sciences Corporation Articles More Stem Cell Sciences Corporation Articles Corporate Summary (site quote): Stem Cell Sciences (SCS) is an international company with centres in the United Kingdom, Australia and Japan....
Posted in Today's Stem Cell Research on April 21, 2005 08:35 PM
Banking Cord Blood from Sibling of a Child that Could Benefit from a Transplant Feasible
At the European Bone Marrow Transplant Group, further reserach results were presented showing that parents of children who have certain health problems that would benefit from a stem cell transplant should consider collecting and banking umbilical cord blood from a...
Posted in Today's Stem Cell Research on April 14, 2005 09:12 PM
U.K. Scientists Weigh in Behind MPs in Controversy over Stem Cell Research
Scientists in the United Kingdom have supported a controversial proposal by MPs that will allow the creation of human-animal hybrids for medical research. They said that the use of such hybrids could potentially provide an answer to the shortage of...
Posted in Today's Stem Cell Research on March 26, 2005 11:23 PM
United Kingdom Scientists Funding Boost
The funding boost for research and development was welcomed by scientists and chancellor's in universities and industry today. Gordon Brown used his regular budget speech to announce new partnerships in stem cell and energy research as part of the government's...
Posted in Today's Stem Cell Research on March 17, 2005 01:00 PM
Experts Available to Discuss Using RNA Interference to Treat ALS
Two studies show RNA interference may slow down the progression of amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's disease, according to an article by Reuters. ALS is a fatal, motor neuron illness, which results in muscle loss and...
Posted in Today's Stem Cell Research on March 15, 2005 10:47 AM
United Nations Urges Ban of All Human Cloning .. In Win for Bush Administration
The UN General Assembly yesterday urged governments to ban all human cloning, including the cloning of human embryos for stem-cell research, in a divided vote... symbolic victory to the administration of President Bush. After effectively four years of contentious debate,...
Posted in Today's Stem Cell Research on March 9, 2005 12:51 PM
United Kingdom Commits to £1 Billion in Biotech Spending
UK biotechnology funding, which includes stem cell research and DNA based medicines and Nanotechnology, will increase to over £1billion over the next three years according to the new science spending allocations announced today. The new funding allocations which were announced...
Posted in Today's Stem Cell Research on March 9, 2005 12:45 PM
Lynx Stockholders Approve Solexa-Lynx Business Combination
Lynx Therapeutics, Inc. (Nasdaq:LYNX) today announced that Lynx stockholders have approved all six proposed items included in the Company's Proxy Statement/Prospectus at today's Annual Meeting of Stockholders, including the proposed business combination with United Kingdom-based Solexa Limited. Of votes cast...
Posted in Today's Stem Cell Research on March 2, 2005 03:22 AM
Regenerative Medicine Discussion at University of Houston in Texas
Professor Dame Julia Polak, a pioneer in stem cell research and regenerative medicine, will speak at the University of Houston at 4:15 p.m., Tuesday, on March the 8th. The event is open to the public. In the seminar on "Stem...
Posted in Today's Stem Cell Research on March 2, 2005 03:14 AM
CHEMICON International Corp. Sheet
CHEMICON International Corp. Articles More CHEMICON International Corp. Articles Corporate Summary (site quote): CHEMICON International, Inc. has been in operation since 1981, supplying immunological reagents to the biomedical research community. In 1992, CHEMICON expanded into the area of diagnostic...
Posted in Today's Stem Cell Research on February 28, 2005 01:29 PM
United Kingdom: Sheffield University hoping To Profit From Stem Cell Venture
A company controlled by the University of Sheffield is seeking to raise £10m to fund the commercialisation of its academics' discoveries, ranging from stem-cell science to repairing severely burned skin. Biofusion is 70% owned by the university and has stakes...
Posted in Today's Stem Cell Research on February 12, 2005 01:49 AM
United Kingdom: Dr. Melissa Carpenter is Returning to California, Leaving Robarts Research Institute in London
Two years after crowing the recruitment of one of North America's top stem cell scientists, the Robarts Research Institute is now losing the leading-edge researcher. Dr. Melissa Carpenter is leaving to work for a biotechnology firm in San Diego, Calif.,...
Posted in Today's Stem Cell Research on February 11, 2005 11:36 PM
United Kingdom: Stem Cell Scientists Lead in Genetic Disease Fight
New laboratory cultures of human embryonic stem cells containing the DNA programmes of 18 specific genetic diseases were unveiled today by British and US scientists. Now, more than 120 human embryonic stem (HES) cell lines have been developed by the...
Posted in Today's Stem Cell Research on February 10, 2005 01:42 AM